Northwestern Medicine scientists have discovered how calcium signaling channels in microglia—the primary immune cells of the brain—regulate neuroinflammation and promote the development of behaviors ...

Beta-blockers are having a moment online. How do these pills work and do they help anxiety? Experts break down the benefits and risks.

Aisa Pharma announces positive results from phase 2 RECONNOITER trial of cilnidipine in patients with systemic sclerosis-associated Raynaud's phenomenon: Boston Monday, March 9, 2 ...

Aisa Pharma has reported positive results from its Phase II RECONNOITER trial of AISA-021 (cilnidipine), a once-daily calcium channel blocker, for patients with systemic sclerosis-associated Raynaud’s ...

Aisa Pharma, Inc., a clinical-stage biopharmaceutical company focused on therapies for systemic sclerosis, today announced results from its Phase 2 RECONNOITER trial of AISA-021 (cilnidipine), a novel ...

Zealand Pharma announces positive Phase 1a topline results with Kv1.3 channel blocker ZP9830 Single doses of ZP9830 were well tolerated, with no serious or severe adverse events or dose-limiting ...

Single doses of ZP9830 were well tolerated, with no serious or severe adverse events or dose-limiting safety findings observed at any dose level ZP9830 exhibited a pharmacokinetic profile in line with ...

Julia Ries Wexler is a writer focusing on all things health and wellness. She has over 10 years of experience in health journalism, and though she has written about pretty much every health topic ...

If you have hypertrophic cardiomyopathy (HCM) and are experiencing symptoms such as shortness of breath, chest pain, dizziness, and difficulty exercising, your doctor might suggest that you start ...

The MarketWatch News Department was not involved in the creation of this content. SAN DIEGO, Jan. 6, 2026 /PRNewswire/ -- HUYABIO International today announced favorable Phase 1 clinical data for ...